OMCL

What one share of Omnicell holds

Electronic Computers

Omnicell, a leading healthcare technology provider focused on empowering autonomous medication management, is committed to solving the critical challenges inherent in medication management and elevating the role of clinicians within healthcare as an essential component of care delivery.

Omnicell’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.

Per-share figures
Sales$27.05
Profit$0.85
Capex (buildings and equipment)$0.84
Free cash flow$3.09
Cash and investments$6.41
Debt$3.69
Book value$28.32

Per share by fiscal year

YearSalesProfitCapexFree cashDividendsBook value
2016$18.88$0.26$0.36$0.99—$12.53
2017$18.41$0.79$0.40$0.25—$14.42
2018$19.41$0.93$0.58$1.98—$16.85
2019$20.89$1.43$0.37$3.01—$20.06
2020$20.40$0.74$0.52$3.73—$22.61
2021$23.61$1.62$0.60$4.23—$25.96
2022$28.24$0.12$1.04$0.66—$25.26
2023$25.37−$0.45$0.92$3.09—$26.11
2024$24.05$0.27$0.79$3.27—$26.81
2025$25.56$0.04$0.87$1.87—$27.36